Skip to main content
← All data ties

Epidemiology And Laboratory Capacity (CFDA 93.323) in Colorado

USAspending.gov records $863,398,518.80 in Epidemiology And Laboratory Capacity For Infectious Diseases (ELC) obligations under CFDA 93.323 with place of performance in Colorado, on 3 awards. Dividing $863,398,518.80 by 3 awards yields about $287.8 million per award. Tennessee’s 93.323 join in this harvest also uses 3 awards, against $756,446,539.84. Same row count, different dollar totals. The page joins 93.323 to state CO. It is not a case-count chart.

Key figures

  • CFDA 93.323 shows $863,398,518.80 in Colorado obligations on 3 awards.
  • Mean obligation is about $287.8 million per award.
  • ELC is not CFDA 93.354 crisis response and not NIH 93.855 research.
  • Figures are USAspending obligations, not outlays.

Three ELC awards carry the Colorado total

CFDA 93.323 is titled Epidemiology And Laboratory Capacity For Infectious Diseases (ELC). Colorado is the place-of-performance state. $863,398,518.80 is the obligation sum on records that carry both keys. Three awards against that total is an extreme concentration short of a single-instrument cell. The packet does not name the state health department, CDC cooperative-agreement years, or pathogens. The join is a two-key filter, not a timeline of outbreaks.

The Colorado hub totals every program. The national 93.323 hub totals every state. This tie is the overlap. Public Health Crisis Response (93.354) is a different emergency catalog line. Geosciences, Post-9/11 education, NEW ERA, and health centers also appear as Colorado joins in this harvest. None of those CFDA numbers sit inside $863,398,518.80.

Three awards against $863,398,518.80 is the same instrument count as Tennessee’s ELC cell. Colorado’s dollar total is higher, so the mean near $287.8 million exceeds Tennessee’s about-$252.1 million. Higher mean is not more disease. Colorado’s crowded join set in this harvest also includes Geosciences, GI Bill, NEW ERA, and health centers. Those overlays do not belong in the ELC table. $863,398,518.80 is CFDA 93.323 only.

ELC is not every CDC infectious-disease line

Epidemiology and laboratory capacity is a specific assistance title. Allergy and infectious diseases research (93.855) is NIH research, not ELC. CDC investigations and technical assistance (93.283) is another operations line. Folding those codes into $863,398,518.80 would misstate this cell. Packet facts are the obligation total, 3 awards, state CO, and CFDA 93.323.

Place of performance tagged Colorado can cover a statewide public-health laboratory award. Awards coded to neighboring states stay on other 93.323 ties. The geography key is not a county outbreak map.

Colorado as the state filter

Colorado is USAspending state code CO. $863,398,518.80 is not Colorado’s entire public-health budget and is not every federal infectious-disease dollar in the state. The packet has no test-volume figure.

Statewide Colorado federal spending is the parent. CFDA 93.323 is one HHS line. Readers comparing laboratory capacity with veterans education or rural-energy awards in Colorado should keep the program numbers distinct.

A mean near $287.8 million

Average obligation is about $287.8 million ($863,398,518.80 ÷ 3). With three rows, the mean is sensitive to each instrument. Tennessee’s 93.323 mean in this harvest is about $252.1 million on the same three-award count and a smaller dollar total. Neither mean is the cost of one laboratory test.

Net obligations can include downward adjustments after a cooperative-agreement period. This page reports $863,398,518.80 as given. Obligations are not outlays.

What the Colorado–93.323 pair is not

A shared state tag does not mean Colorado selected these awards as competitive earmarks, and it does not mean ELC outlays equal $863,398,518.80. FEC donations do not fund this USAspending cell. Correlation is not causation.

Continue from Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in Colorado for the overlay, CFDA 93.323 for the national program, Colorado federal spending for the state total, Colorado programs for other CFDA lines, and All spending ties for other pairs.

ELC overlay among Colorado’s many program joins

Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in Colorado is the overlay for CFDA 93.323 inside state CO. Three awards and $863,398,518.80 will look like a short table next to Colorado’s 1,576-award GI Bill cell or 247-award Geosciences cell. Short is the instrument count for this CFDA, not a missing statewide laboratory total. Tennessee’s ELC join also uses three awards against a smaller dollar total. Matching row counts do not rank pathogens.

Crisis response (93.354) and NIAID research (93.855) are different infectious-disease-adjacent catalogs used on other state joins in this harvest. Do not fold them into $863,398,518.80. Colorado programs is the CFDA index. The national 93.323 hub drops the Colorado filter. Test volumes and after-action reports are outside the facts. Obligations are not outlays. Treat about $287.8 million as a mean across three records, not as the cost of one assay.

Questions

How much ELC infectious-disease funding is obligated in Colorado?
USAspending records $863,398,518.80 in CFDA 93.323 obligations with Colorado place of performance, on 3 awards. That is an obligation aggregate, not outlays.
Is ELC the same as public health crisis-response funding?
No. This cell is CFDA 93.323 only. Crisis-response cooperative agreements use 93.354 and are not included in $863,398,518.80.
What is the average 93.323 award in Colorado?
Dividing $863,398,518.80 by 3 awards produces about $287.8 million per award. That mean is not a median and not a per-test cost.
Does this include all federal spending in Colorado?
No. Only CFDA 93.323 is in this cell. Other programs appear on the Colorado programs index.

USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.